Intel fell 3.3%, and Nvidia suspended testing of Intel's 18A process. Nike rose 2.7%, and recently received a “diff purchase” of 50,000 shares by Apple CEO Cook. UiPath rose 6.9% and was included as a component of the S&P Mid Cap 400 Index. Denavi Pharmaceuticals rose 39.3%, and Sanofi spent about $2.2 billion to acquire the company.

Intel fell 3.3%, and Nvidia suspended testing of Intel's 18A process. Nike rose 2.7%, and recently received a “diff purchase” of 50,000 shares by Apple CEO Cook. UiPath rose 6.9% and was included as a component of the S&P Mid Cap 400 Index. Denavi Pharmaceuticals rose 39.3%, and Sanofi spent about $2.2 billion to acquire the company.